Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Feb. 25, 2021, 4:32 p.m. EST

Moderna Inc. stock outperforms competitors on strong trading day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA advanced 2.48% to $148.38 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 3.52% to 13,119.43 and Dow Jones Industrial Average DJIA falling 1.75% to 31,402.01. The stock's rise snapped a three-day losing streak. Moderna Inc. closed $40.88 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV fell 1.25% to $107.33, Amgen Inc. AMGN fell 1.07% to $227.52, and AstraZeneca PLC ADR AZN fell 0.53% to $48.91. Trading volume (15.1 M) remained 2.6 million below its 50-day average volume of 17.6 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.